REZOLUTE, INC. Form PRE 14A: Preliminary proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-10-10: Form PRE 14A; Period of report 2024-12-05; Description PRE 14A; Document tm2425798-1_pre14a.htm.
- 2022-05-06: Form PRE 14A; Period of report 2022-06-16; Description PRE 14A; Document tm223666-1_pre14a.htm.
- 2021-04-12: Form PRE 14A; Period of report 2021-05-12; Description PRE 14A; Document tm2112512-1_pre14a.htm.
- 2019-09-06: Form PRE 14A; Period of report 2019-10-23; Description PRE 14A; Document tv528938_pre14a.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2024-10-10 | PRE 14A | 2024-12-05 | PRE 14A | tm2425798-1_pre14a.htm |
| 2022-05-06 | PRE 14A | 2022-06-16 | PRE 14A | tm223666-1_pre14a.htm |
| 2021-04-12 | PRE 14A | 2021-05-12 | PRE 14A | tm2112512-1_pre14a.htm |
| 2019-09-06 | PRE 14A | 2019-10-23 | PRE 14A | tv528938_pre14a.htm |
| 2019-03-11 | PRE 14A | 2019-03-08 | PRE 14A | tv515787_pre14a.htm |
| 2017-09-27 | PRE 14A | 2017-09-27 | PRE 14A | v475713_pre14a.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |